Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
Details for Australian Patent Application No. 2006297443 (hide)
International Classifications
Event Publications
3 April 2008 PCT application entered the National Phase
PCT publication WO2007/041052 Priority application(s): WO2007/041052
28 January 2010 Alteration of Name
The name of the applicant has been altered to Merck Sharp & Dohme Corp.
12 August 2010 Application Accepted
Published as AU-B-2006297443
9 December 2010 Standard Patent Sealed
11 October 2012 Alteration of Name
The name of the patentee has been altered to Merck Sharp & Dohme Corp.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006297444-Formulation comprising metformin and vildagli ptin
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser